We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Federal Circuit Affirms Ultracet Decision

Law360 (January 19, 2007, 12:00 AM EST) -- The U.S. Court of Appeals for the Federal Circuit upheld a lower court ruling Friday that allowed a subsidiary of India’s Sun Pharmaceuticals to market a generic version of Johnson & Johnson’s pain medication Ultracet.

The court’s three-judge panel said that after “considering the intrinsic and extrinsic evidence in this case” there was no error in the district court’s construction of the terms in the case. And under the district court’s claim construction, the appeals court said there was not literal infringement.

The appeals court also...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.